We are live on
!
Find out more
William Blair & Company Portfolio holdings
AUM
$38.4B
1-Year Est. Return
25.71%
This Fund
S&P 500
This Quarter
Est. Return
+6.81%
1 Year Est. Return
+25.71%
3 Year Est. Return
+88.7%
5 Year Est. Return
+104.53%
10 Year Est. Return
+665.86%
AUM
$17.5B
AUM Growth
+$1.09B
(+6.6%)
Cap. Flow
+$196M
Cap. Flow
% of AUM
1.12%
Top 10 Holdings %
Top 10 Hldgs %
22.04%
Holding
1,814
New
115
Increased
670
Reduced
633
Closed
80
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FISV
Fiserv Inc
FISV
|
+$41.9M |
| 2 |
Dolby
DLB
|
+$23M |
| 3 |
Teladoc Health
TDOC
|
+$20.9M |
| 4 |
Copart
CPRT
|
+$20.8M |
| 5 |
DexCom
DXCM
|
+$16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RHT
Red Hat Inc
RHT
|
+$144M |
| 2 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$103M |
| 3 |
Gilead Sciences
GILD
|
+$16.4M |
| 4 |
Blackstone
BX
|
+$12.4M |
| 5 |
Veeva Systems
VEEV
|
+$10.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.57% |
| 2 | Healthcare | 17.89% |
| 3 | Financials | 12.54% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Corcept Therapeutics
CORT
$12.1B
| $290K | ﹤0.01% |
26,005
-995
| -4% | -$11.1K |
|
1152
Clearway Energy Class C
CWEN
$7.06B
| $290K | ﹤0.01% |
17,222
| – | – |
|
|
SCWX
1153
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $288K | ﹤0.01% |
21,704
-21,425
| -50% | -$356K |
|
1154
AZZ Inc
AZZ
$4.55B
| $287K | ﹤0.01% |
6,235
| – | – |
|
1155
Schwab US TIPS ETF
SCHP
$16.2B
| $286K | ﹤0.01% |
10,152
-2,076
| -17% | -$57.5K |
|
1156
Las Vegas Sands
LVS
$29.6B
| $283K | ﹤0.01% |
4,789
+1,188
| +33% | +$73.6K |
|
1157
MPLX
MPLX
$60.8B
| $282K | ﹤0.01% |
8,770
-1,259
| -13% | -$40.1K |
|
1158
Pinnacle West Capital
PNW
$12.2B
| $282K | ﹤0.01% |
2,999
-6
| -0.2% | -$572 |
|
1159
Invesco S&P MidCap Momentum ETF
XMMO
$7.63B
| $282K | ﹤0.01% |
4,800
-650
| -12% | -$37.7K |
|
|
AEF
1160
abrdn Emerging Markets Equity Income Fund
AEF
$380M
| $279K | ﹤0.01% |
38,125
| – | – |
|
|
QADA
1161
DELISTED
QAD Inc.
QADA
| $279K | ﹤0.01% |
6,929
-824
| -11% | -$36.7K |
|
1162
iShares Intermediate Government/Credit Bond ETF
GVI
$3.79B
| $277K | ﹤0.01% |
2,469
+857
| +53% | +$94.8K |
|
1163
HUB Group
HUBG
$2.46B
| $276K | ﹤0.01% |
13,150
-50
| -0.4% | -$1.05K |
|
1164
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.97B
| $275K | ﹤0.01% |
6,158
-5,485
| -47% | -$240K |
|
1165
iShares MSCI Brazil ETF
EWZ
$8.57B
| $275K | ﹤0.01% |
6,285
-102
| -2% | -$4.21K |
|
1166
Nucor
NUE
$61.7B
| $275K | ﹤0.01% |
4,989
-1,305
| -21% | -$71.7K |
|
1167
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
| $274K | ﹤0.01% |
3,167
-90
| -3% | -$7.6K |
|
1168
iShares MSCI Pacific ex Japan ETF
EPP
$2.26B
| $274K | ﹤0.01% |
5,793
+1,275
| +28% | +$59K |
|
1169
ADT
ADT
$5.34B
| $273K | ﹤0.01% |
+6,500
| New | +$41.4K |
|
1170
HealthEquity
HQY
$8.82B
| $273K | ﹤0.01% |
+4,176
| New | +$291K |
|
1171
ONE Gas
OGS
$5.05B
| $273K | ﹤0.01% |
3,027
+360
| +13% | +$31.8K |
|
|
PPL
1172
PPL Corp
PPL
$26.7B
| $273K | ﹤0.01% |
8,799
+91
| +1% | +$2.82K |
|
1173
iShares MSCI ACWI ex US ETF
ACWX
$12B
| $272K | ﹤0.01% |
5,810
-3,935
| -40% | -$183K |
|
1174
iShares US Consumer Staples ETF
IYK
$1.42B
| $272K | ﹤0.01% |
6,711
+3
| +0% | +$121 |
|
1175
Takeda Pharmaceutical
TAK
$55.6B
| $272K | ﹤0.01% |
15,384
-806
| -5% | -$14.7K |
|
Similar funds
HF
William Blair & Company's Q2 2019 Portfolio in Review
As of Q2 2019, William Blair & Company held 1,814 positions worth $17.5B, up 6.6% from $16.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
William Blair & Company's Q2 2019 filing shows 115 new, 670 increased, 633 reduced and 80 closed positions. Its largest new stake was Q2 Holdings: 213,468 shares worth $16.3M. The largest sale was Red Hat Inc, an estimated $144M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- William Blair & Company's largest Q2 2019 buy was Q2 Holdings: 213,468 shares worth $16.3M.
- William Blair & Company added most to Fiserv Inc in Q2 2019, an estimated $41.9M increase.
- William Blair & Company's biggest Q2 2019 reduction was Gilead Sciences, cutting an estimated $16.4M.
- William Blair & Company fully exited Red Hat Inc in Q2 2019, selling an estimated $144M.
- William Blair & Company's ten largest holdings make up 22% of its $17.5B portfolio in Q2 2019.
- William Blair & Company opened 115 new positions and closed 80 in Q2 2019.
- William Blair & Company's portfolio value rose 6.6% quarter-over-quarter to $17.5B.
Based on William Blair & Company's 13F filing for Q2 2019, filed 13 Aug 2019.